If the world is single-minded and focuses purely on combating one pandemic, forgetting others, the effects of other morbidity and mortality on healthcare systems will be seen for a long time to come.
Academic rigour, journalistic flair
Articles on Antiretroviral therapy
Displaying 21 - 40 of 56 articles
Nurses represent 50% of the global healthcare workforce. And they are often the sole healthcare providers in many low and middle-income countries.
The giant leap in the number of people accessing HIV treatment would not have been possible without task shifting from medical doctors to less-specialised cadres such as nurses and midwives.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
The use of antiretroviral therapy among pregnant and breastfeeding women in Zambia has increased but adherence is a problem.
Pooled testing, or group testing, has been used to diagnose relatively rare conditions, such as infection in blood donors. It could be used for universal early infant diagnosis and viral load testing.
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
Reducing maternal deaths in developing countries relies on the ability of health systems to swiftly identify and manage women at high risk.
In Eswatini, Botswana, South Africa and Lesotho more than 1 in 5 children are HIV-exposed but uninfected. A coordinated strategy is needed to ensure all children reach their developmental potential.
South Africa has set ambitious targets to eliminate mother to child transmission of HIV completely. It will require innovative strategies and continuous quality improvement to achieve them.
Babies born with the HIV virus in their blood are at a turning point in the infection. With immediate treatment these children can develop much stronger immune systems to fight the virus.
New research supports kidney transplants from HIV-positive donors to recipients with HIV.
There’s an urgent need for interventions to increase uptake of antiretroviral therapy and improve services for adolescents.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
Rapid population ageing has prompted researchers to study disease trends in older South Africans. The aim is to understand the role that specific health conditions play in ageing among rural people.
Research done over the past 26 years
provides insights into changes across people’s lives, helps evaluate interventions, and provides information for local, provincial and national planning.
The study confirms that dolutegravir is an effective and well-tolerated ARV.
Research shows that many people living with HIV struggle with tooth decay, bleeding gums and tooth sensitivity – due to the costs of dental care and discrimination by dental professionals.
Most of the reasons people don’t take their medication aren’t related to the antiretrovirals themselves, but rather social and systemic issues.
Until then we need to get effective, accessible treatment for all who need it, while deploying the many prevention tools at our disposal.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Senior lecturer in Paediatrics and Child Health, Stellenbosch University
-
Professor: Health and Population Division, School of Public Health, University of the Witwatersrand
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Health Systems Researcher, Makerere University
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand
-
University of the Witwatersrand
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Research Fellow, Wits School of Public Health, University of the Witwatersrand
-
Head: Cell Biology, Centre for HIV and STIs, National Institute for Communicable Diseases
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Assistant Professor, Harvard University
-
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
-
Public Health Medicine Specialist, University of the Witwatersrand
-
Associate Professor and Director of the Centre for Infectious Diseases Epidemiology and Research, University of Cape Town
